title: [Colorectal carcinoma: what's new?].
authors.affiliation: Medizinische Universitätsklinik, Knappschaftskrankenhaus Bochum, Klinikum der Ruhr-Universität Bochum. christian.p.pox@rub.de
authors.forename: C
authors.initials: C
authors.lastname: Pox
authors.forename: W
authors.initials: W
authors.lastname: Schmiegel
authors.forename: A
authors.initials: A
authors.lastname: Reinacher-Schick
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000069287:Capecitabine; D017024:Chemotherapy, Adjuvant; D003082:Colectomy; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000517:prevention & control / Q000628:therapy*; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D019160:Endosonography; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000556:secondary / Q000628:therapy; D008403:Mass Screening; D059146:Metastasectomy; D064847:Multimodal Imaging; D009367:Neoplasm Staging; D009780:Occult Blood; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D000077150:Oxaliplatin; D010671:Phenylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects; D049268:Positron-Emission Tomography; D017410:Practice Guidelines as Topic; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects; D016879:Salvage Therapy; D014057:Tomography, X-Ray Computed
chemical_list: D009944:Organoplatinum Compounds; D010671:Phenylurea Compounds; D011725:Pyridines; D000077150:Oxaliplatin; D003841:Deoxycytidine; C559147:regorafenib; D000069287:Capecitabine; D005472:Fluorouracil